Literature DB >> 19920163

Atrial flutter versus atrial fibrillation in a general population: differences in comorbidities associated with their respective onset.

Ravi K Mareedu1, Ihab B Abdalrahman, Kodlipet C Dharmashankar, Juan F Granada, Po-Huang Chyou, Param P Sharma, Peter N Smith, John J Hayes, Robert T Greenlee, Humberto Vidaillet.   

Abstract

OBJECTIVE: Determine and compare the prevalence of known risk factors for cardiovascular disease among unselected individuals presenting with their first ever episode of atrial flutter (AFL) and atrial fibrillation (AF). STUDY DESIGN AND
SETTING: We evaluated 11 pre-selected clinical variables including age, sex, smoking history and other potential cardiac risk factors. Using the resources of the Marshfield Epidemiologic Study Area, a population-based database, all newly diagnosed cases of either AFL or AF in the region during a 4-year period were identified.
RESULTS: Among the 472 incident cases, 76 (16.1%) had AFL and 396 (83.9%) had AF. Compared to those with AF, subjects with AFL were more likely to have had a history of chronic obstructive pulmonary disease (25% vs. 12%, P = 0.006), heart failure (28% vs. 17%, P = 0.05), and smoking (49% vs. 37%, P = 0.06). Hypertension, on the other hand, was more common among individuals with AF (63% vs. 47%, P = 0.01).
CONCLUSION: This study represents the first report to evaluate potential differences in the conditions associated with the development of AFL versus AF. Research into the mechanisms of atrial arrhythmogenesis may lead to improved preventive and therapeutic interventions.

Entities:  

Mesh:

Year:  2009        PMID: 19920163      PMCID: PMC2842309          DOI: 10.3121/cmr.2009.851

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  26 in total

Review 1.  Pathophysiology and prevention of atrial fibrillation.

Authors:  M A Allessie; P A Boyden; A J Camm; A G Kléber; M J Lab; M J Legato; M R Rosen; P J Schwartz; P M Spooner; D R Van Wagoner ; A L Waldo
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

2.  ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Jonathan L Halperin; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano
Journal:  Circulation       Date:  2006-08-15       Impact factor: 29.690

Review 3.  Measuring disease frequency in the Marshfield Epidemiologic Study Area (MESA).

Authors:  Robert T Greenlee
Journal:  Clin Med Res       Date:  2003-10

4.  Psychosocial work characteristics predict cardiovascular disease risk factors and health functioning in rural women: the Wisconsin Rural Women's Health Study.

Authors:  Vatsal Chikani; Douglas Reding; Paul Gunderson; Catherine A McCarty
Journal:  J Rural Health       Date:  2005       Impact factor: 4.333

Review 5.  Recent progress in the epidemiology of atrial fibrillation.

Authors:  Robert T Greenlee; Humberto Vidaillet
Journal:  Curr Opin Cardiol       Date:  2005-01       Impact factor: 2.161

6.  Corticosteroids and the risk of atrial fibrillation.

Authors:  Cornelis S van der Hooft; Jan Heeringa; Guy G Brusselle; Albert Hofman; Jacqueline C M Witteman; J Herre Kingma; Miriam C J M Sturkenboom; Bruno H Ch Stricker
Journal:  Arch Intern Med       Date:  2006-05-08

7.  Respiratory medications and the risk of cardiac arrhythmias.

Authors:  Consuelo Huerta; Stephan F Lanes; Luis A García Rodríguez
Journal:  Epidemiology       Date:  2005-05       Impact factor: 4.822

8.  Pulmonary vein antrum isolation for treatment of atrial fibrillation in patients with valvular heart disease or prior open heart surgery.

Authors:  Yaariv Khaykin; Nassir F Marrouche; Walid Saliba; Robert Schweikert; Dianna Bash; Michael S Chen; Michelle Williams-Andrews; Eduardo Saad; David J Burkhardt; Mandeep Bhargava; George Joseph; Antonio Rossillo; Demet Erciyes; David Martin; Andrea Natale
Journal:  Heart Rhythm       Date:  2004-05       Impact factor: 6.343

9.  Acute electrophysiologic effects of inhaled salbutamol in humans.

Authors:  Eleftherios M Kallergis; Emmanuel G Manios; Emmanuel M Kanoupakis; Sophia E Schiza; Hercules E Mavrakis; Nikolaos K Klapsinos; Panos E Vardas
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

10.  Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation.

Authors:  Peter M Kistler; Prashanthan Sanders; Miodrag Dodic; Steven J Spence; Chrishan S Samuel; Chongxin Zhao; Jennifer A Charles; Glenn A Edwards; Jonathan M Kalman
Journal:  Eur Heart J       Date:  2006-11-10       Impact factor: 29.983

View more
  7 in total

1.  Sudden flare of rheumatoid arthritis associated with newly diagnosed atrial flutter.

Authors:  Muthiah Vaduganathan; Joel N Auslander
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-07

Review 2.  Epidemiology of arrhythmias and conduction disorders in older adults.

Authors:  Grant V Chow; Joseph E Marine; Jerome L Fleg
Journal:  Clin Geriatr Med       Date:  2012-11       Impact factor: 3.076

3.  Symptoms and quality of life in patients with coexistent atrial fibrillation and atrial flutter.

Authors:  Samuel Stempfel; Stefanie Aeschbacher; Steffen Blum; Pascal Meyre; Rebecca Gugganig; Jürg H Beer; Richard Kobza; Michael Kühne; Giorgio Moschovitis; Gianluca Menghini; Jan Novak; Stefan Osswald; Nicolas Rodondi; Elisavet Moutzouri; Matthias Schwenkglenks; Fabienne Witassek; David Conen; Christian Sticherling
Journal:  Int J Cardiol Heart Vasc       Date:  2020-06-16

4.  Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study.

Authors:  Faisal Rahman; Na Wang; Xiaoyan Yin; Patrick T Ellinor; Steven A Lubitz; Paul A LeLorier; David D McManus; Lisa M Sullivan; Sudha Seshadri; Ramachandran S Vasan; Emelia J Benjamin; Jared W Magnani
Journal:  Heart Rhythm       Date:  2015-07-28       Impact factor: 6.343

5.  Anticoagulation therapy in patients with stroke and atrial fibrillation: a registry-based study of acute stroke care in Surrey, UK.

Authors:  Thang S Han; Christopher Henry Fry; David Fluck; Brendan Affley; Giosue Gulli; Christopher Barrett; Puneet Kakar; Tasmin Patel; Sapna Sharma; Pankaj Sharma
Journal:  BMJ Open       Date:  2018-07-11       Impact factor: 2.692

6.  Comparison of New-Onset Diabetes Mellitus among Patients with Atrial Fibrillation or Atrial Flutter.

Authors:  Wei Syun Hu; Cheng Li Lin
Journal:  Korean Circ J       Date:  2020-03-13       Impact factor: 3.243

Review 7.  Heart failure and atrial flutter: a systematic review of current knowledge and practices.

Authors:  Michael J Diamant; Jason G Andrade; Sean A Virani; Pardeep S Jhund; Mark C Petrie; Nathaniel M Hawkins
Journal:  ESC Heart Fail       Date:  2021-09-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.